Magdalena Chrabaszcz
Warsaw, MZ, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
BIOMARKERS OF DISEASE ACTIVITY IN SYSTEMIC SCLEROSIS.
Journal: Wiadomosci lekarskie (Warsaw, Poland : 1960)
Published: December 14, 2020
Clinical Implications of Intestinal Barrier Damage in Psoriasis.
Journal: Journal of inflammation research
Published: November 18, 2020
Gut Microbiome in Psoriasis: An Updated Review.
Journal: Pathogens (Basel, Switzerland)
Published: May 08, 2020
Renal Involvement in Systemic Sclerosis: An Update.
Journal: Kidney & blood pressure research
Published: January 07, 2020
Adalimumab - Safe and Effective Therapy for an Adolescent Patient with Severe Psoriasis and Immune Thrombocytopenia.
Journal: Acta dermatovenerologica Croatica : ADC
Published: July 29, 2019
Intestinal Fatty Acid Binding Protein, a Biomarker of Intestinal Barrier, is Associated with Severity of Psoriasis.
Journal: Journal of clinical medicine
Published: June 15, 2019
Claudin-3 - a new intestinal integrity marker in patients with psoriasis: association with disease severity.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: January 23, 2019
Intestinal barrier integrity in patients with plaque psoriasis.
Journal: The Journal of dermatology
Published: July 12, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026